Tyra Biosciences, Inc. (TYRA) Stock Grade

About Tyra Biosciences, Inc.'s fundamentals

Tyra Biosciences is a $1.6 billion market cap biotechnology company with no reported revenue growth year-over-year and a net margin of 0.0%, reflecting that the company reported a net loss in its latest annual statement. The company does not pay a dividend, which is typical for early-stage biotech firms reinvesting resources into research and development. With no meaningful profitability metrics available, valuation multiples like P/E ratio cannot be calculated, indicating the company is still in a pre-profitability stage of development.